GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hey1
|
ENSRNOG00000011593 | hes-related family bHLH transcription factor with YRPW motif 1 |
Myc
|
ENSRNOG00000004500 | myelocytomatosis oncogene |
Mxi1
|
ENSRNOG00000034078 | MAX interactor 1, dimerization protein |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hey1 | rn6_v1_chr2_+_95320283_95320283 | -0.48 | 1.0e-19 | Click! |
Mxi1 | rn6_v1_chr1_+_274030978_274030978 | -0.27 | 6.3e-07 | Click! |
Myc | rn6_v1_chr7_+_102588369_102588369 | -0.09 | 1.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_219759183 | 33.39 |
ENSRNOT00000026316
|
Pc
|
pyruvate carboxylase |
chr20_-_10386663 | 22.39 |
ENSRNOT00000045275
ENSRNOT00000042432 |
Cbs
|
cystathionine beta synthase |
chr3_+_113415774 | 22.25 |
ENSRNOT00000056151
|
Serf2
|
small EDRK-rich factor 2 |
chr8_-_115140080 | 21.45 |
ENSRNOT00000015851
|
Acy1
|
aminoacylase 1 |
chr7_-_73270308 | 21.34 |
ENSRNOT00000007430
|
Rida
|
reactive intermediate imine deaminase A homolog |
chr4_-_157679962 | 21.13 |
ENSRNOT00000050443
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase |
chr9_-_61690956 | 19.01 |
ENSRNOT00000066589
|
Hspd1
|
heat shock protein family D member 1 |
chr5_+_165405168 | 18.06 |
ENSRNOT00000014934
|
Srm
|
spermidine synthase |
chr1_+_247228061 | 16.95 |
ENSRNOT00000020809
|
Rcl1
|
RNA terminal phosphate cyclase-like 1 |
chr8_+_85059051 | 16.47 |
ENSRNOT00000033196
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit |
chr8_+_116343096 | 16.23 |
ENSRNOT00000022092
|
Ifrd2
|
interferon-related developmental regulator 2 |
chr10_+_103395511 | 15.35 |
ENSRNOT00000004256
|
Gprc5c
|
G protein-coupled receptor, class C, group 5, member C |
chr5_-_147784311 | 15.32 |
ENSRNOT00000074172
|
Fam167b
|
family with sequence similarity 167, member B |
chr3_+_72238981 | 14.85 |
ENSRNOT00000011006
|
Slc43a1
|
solute carrier family 43 member 1 |
chr2_-_197991198 | 14.59 |
ENSRNOT00000056322
|
Ciart
|
circadian associated repressor of transcription |
chr8_+_50559126 | 14.52 |
ENSRNOT00000024918
|
Apoa5
|
apolipoprotein A5 |
chr1_-_204605552 | 14.37 |
ENSRNOT00000022904
|
Nkx1-2
|
NK1 homeobox 2 |
chr7_-_70829815 | 14.12 |
ENSRNOT00000011082
|
Shmt2
|
serine hydroxymethyltransferase 2 |
chr5_+_120250616 | 13.99 |
ENSRNOT00000070967
|
Ak4
|
adenylate kinase 4 |
chr14_-_70121797 | 13.76 |
ENSRNOT00000004770
|
Lap3
|
leucine aminopeptidase 3 |
chr10_+_61432819 | 13.41 |
ENSRNOT00000003687
ENSRNOT00000092478 |
Cluh
|
clustered mitochondria homolog |
chr12_+_23473270 | 13.33 |
ENSRNOT00000001935
|
Sh2b2
|
SH2B adaptor protein 2 |
chr5_+_167141875 | 13.31 |
ENSRNOT00000089314
|
Slc2a5
|
solute carrier family 2 member 5 |
chr15_+_4554603 | 13.19 |
ENSRNOT00000075153
|
Kcnk5
|
potassium two pore domain channel subfamily K member 5 |
chr2_-_211017778 | 12.86 |
ENSRNOT00000026883
|
Sypl2
|
synaptophysin-like 2 |
chrX_+_25016401 | 12.66 |
ENSRNOT00000059270
|
Clcn4
|
chloride voltage-gated channel 4 |
chr14_-_33580566 | 12.61 |
ENSRNOT00000063942
|
Paics
|
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase |
chr19_-_49532811 | 12.58 |
ENSRNOT00000015967
|
Gcsh
|
glycine cleavage system protein H |
chr16_-_54513349 | 12.54 |
ENSRNOT00000014809
ENSRNOT00000015127 |
Slc7a2
|
solute carrier family 7 member 2 |
chr1_-_265899958 | 12.47 |
ENSRNOT00000026013
|
Pitx3
|
paired-like homeodomain 3 |
chr8_+_117117430 | 12.46 |
ENSRNOT00000073247
|
Gpx1
|
glutathione peroxidase 1 |
chr1_+_266333440 | 12.29 |
ENSRNOT00000071243
|
Sfxn2
|
sideroflexin 2 |
chr10_+_16542882 | 12.13 |
ENSRNOT00000028146
|
Stc2
|
stanniocalcin 2 |
chr14_+_33580541 | 11.57 |
ENSRNOT00000002905
|
Ppat
|
phosphoribosyl pyrophosphate amidotransferase |
chr1_-_82452281 | 11.56 |
ENSRNOT00000027995
|
Bckdha
|
branched chain ketoacid dehydrogenase E1, alpha polypeptide |
chr3_-_10375826 | 11.56 |
ENSRNOT00000093365
|
Ass1
|
argininosuccinate synthase 1 |
chr6_+_80220547 | 11.37 |
ENSRNOT00000086221
ENSRNOT00000077435 ENSRNOT00000059318 ENSRNOT00000089010 |
Mia2
|
melanoma inhibitory activity 2 |
chr10_-_82852660 | 11.28 |
ENSRNOT00000005641
|
Pdk2
|
pyruvate dehydrogenase kinase 2 |
chr9_-_82419288 | 11.09 |
ENSRNOT00000004797
|
Tuba4a
|
tubulin, alpha 4A |
chr7_+_123043503 | 10.88 |
ENSRNOT00000026258
ENSRNOT00000086355 |
Tef
|
TEF, PAR bZIP transcription factor |
chr1_+_12823363 | 10.80 |
ENSRNOT00000086790
|
Cited2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
chr10_-_83898527 | 10.75 |
ENSRNOT00000009815
|
Atp5g1
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) |
chr5_-_137372524 | 10.66 |
ENSRNOT00000009061
|
Tmem125
|
transmembrane protein 125 |
chr15_-_52029816 | 10.59 |
ENSRNOT00000013067
|
Slc39a14
|
solute carrier family 39 member 14 |
chr5_+_137371825 | 10.38 |
ENSRNOT00000072816
|
Tmem125
|
transmembrane protein 125 |
chr10_-_81653717 | 10.17 |
ENSRNOT00000003611
|
Nme2
|
NME/NM23 nucleoside diphosphate kinase 2 |
chr3_+_126335863 | 9.87 |
ENSRNOT00000028904
|
Bmp2
|
bone morphogenetic protein 2 |
chr2_-_260596777 | 9.85 |
ENSRNOT00000009370
|
Lhx8
|
LIM homeobox 8 |
chr5_+_151776004 | 9.80 |
ENSRNOT00000009683
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2 |
chr5_+_158090173 | 9.73 |
ENSRNOT00000088766
ENSRNOT00000079516 ENSRNOT00000092026 |
Tas1r2
|
taste 1 receptor member 2 |
chr2_-_264293010 | 9.70 |
ENSRNOT00000082532
ENSRNOT00000067843 |
LOC103691744
|
cystathionine gamma-lyase |
chr14_-_86297623 | 9.70 |
ENSRNOT00000067162
ENSRNOT00000081607 ENSRNOT00000085265 |
Camk2b
|
calcium/calmodulin-dependent protein kinase II beta |
chr10_+_84135116 | 9.64 |
ENSRNOT00000031035
|
Hoxb7
|
homeo box B7 |
chr4_+_85009350 | 9.56 |
ENSRNOT00000072271
|
Znrf2
|
zinc and ring finger 2 |
chr2_-_30246010 | 9.30 |
ENSRNOT00000023900
|
Mccc2
|
methylcrotonoyl-CoA carboxylase 2 |
chr19_-_601469 | 9.20 |
ENSRNOT00000016462
|
Pdp2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
chr8_+_50310405 | 9.15 |
ENSRNOT00000073507
|
Sik3
|
SIK family kinase 3 |
chr10_-_62287189 | 8.90 |
ENSRNOT00000004365
|
Wdr81
|
WD repeat domain 81 |
chr5_-_138470096 | 8.87 |
ENSRNOT00000011392
|
Ppcs
|
phosphopantothenoylcysteine synthetase |
chrX_+_156863754 | 8.61 |
ENSRNOT00000083611
|
Naa10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit |
chr6_+_42852683 | 8.57 |
ENSRNOT00000079185
|
Odc1
|
ornithine decarboxylase 1 |
chr18_-_31071371 | 8.55 |
ENSRNOT00000060432
|
Diaph1
|
diaphanous-related formin 1 |
chr9_-_82382272 | 8.54 |
ENSRNOT00000025627
|
Abcb6
|
ATP-binding cassette, subfamily B (MDR/TAP), member 6 |
chr17_+_9830332 | 8.48 |
ENSRNOT00000021946
|
Rab24
|
RAB24, member RAS oncogene family |
chr8_-_47529689 | 8.36 |
ENSRNOT00000012826
|
Oaf
|
out at first homolog |
chr14_-_2032593 | 8.34 |
ENSRNOT00000000037
|
Fgfrl1
|
fibroblast growth factor receptor-like 1 |
chr3_+_14588870 | 8.16 |
ENSRNOT00000071712
|
LOC100912604
|
spermidine synthase-like |
chr2_-_197991574 | 8.15 |
ENSRNOT00000085632
|
Ciart
|
circadian associated repressor of transcription |
chr1_+_100393303 | 8.13 |
ENSRNOT00000026251
|
Syt3
|
synaptotagmin 3 |
chr3_+_2182957 | 7.97 |
ENSRNOT00000011633
|
Pnpla7
|
patatin-like phospholipase domain containing 7 |
chr13_+_48745860 | 7.95 |
ENSRNOT00000010242
|
Slc45a3
|
solute carrier family 45, member 3 |
chr20_+_31265483 | 7.95 |
ENSRNOT00000079584
ENSRNOT00000000674 |
Ppa1
|
pyrophosphatase (inorganic) 1 |
chr10_-_84881190 | 7.88 |
ENSRNOT00000073746
|
Pnpo
|
pyridoxamine 5'-phosphate oxidase |
chr2_-_187160373 | 7.62 |
ENSRNOT00000018961
|
Ntrk1
|
neurotrophic receptor tyrosine kinase 1 |
chr9_-_16848503 | 7.60 |
ENSRNOT00000024815
|
Dnph1
|
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
chr5_+_140979435 | 7.59 |
ENSRNOT00000056592
|
Pabpc4
|
poly(A) binding protein, cytoplasmic 4 |
chr10_+_14216155 | 7.54 |
ENSRNOT00000020192
|
Hagh
|
hydroxyacyl glutathione hydrolase |
chr9_+_55050203 | 7.52 |
ENSRNOT00000021403
|
Nabp1
|
nucleic acid binding protein 1 |
chr2_-_52282548 | 7.51 |
ENSRNOT00000033627
|
Nnt
|
nicotinamide nucleotide transhydrogenase |
chr10_-_88842233 | 7.47 |
ENSRNOT00000026760
|
Stat3
|
signal transducer and activator of transcription 3 |
chr5_+_156810991 | 7.47 |
ENSRNOT00000055904
|
AABR07050222.1
|
|
chr13_+_44424689 | 7.40 |
ENSRNOT00000005206
|
Acmsd
|
aminocarboxymuconate semialdehyde decarboxylase |
chr10_-_37209881 | 7.38 |
ENSRNOT00000090475
|
Sec24a
|
SEC24 homolog A, COPII coat complex component |
chr5_+_160306727 | 7.37 |
ENSRNOT00000016648
|
Agmat
|
agmatinase |
chr10_-_14215957 | 7.30 |
ENSRNOT00000019767
|
Fahd1
|
fumarylacetoacetate hydrolase domain containing 1 |
chr2_-_9578310 | 7.29 |
ENSRNOT00000021804
|
Polr3g
|
RNA polymerase III subunit G |
chr3_+_161298962 | 7.26 |
ENSRNOT00000066028
|
Ctsa
|
cathepsin A |
chr4_-_82194927 | 7.25 |
ENSRNOT00000072302
|
LOC103692128
|
homeobox protein Hox-A9 |
chr4_+_159563798 | 7.24 |
ENSRNOT00000081426
|
Fgf6
|
fibroblast growth factor 6 |
chr19_-_43149210 | 7.20 |
ENSRNOT00000038452
|
Pdpr
|
pyruvate dehydrogenase phosphatase regulatory subunit |
chr15_+_34234193 | 7.19 |
ENSRNOT00000077584
|
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr3_-_138397870 | 7.19 |
ENSRNOT00000074606
|
Snx5
|
sorting nexin 5 |
chr9_+_16314173 | 7.18 |
ENSRNOT00000072812
|
LOC100911564
|
glycine N-methyltransferase-like |
chr15_+_8730871 | 7.15 |
ENSRNOT00000081845
|
Nr1d2
|
nuclear receptor subfamily 1, group D, member 2 |
chr1_+_220114228 | 7.03 |
ENSRNOT00000026718
|
Ctsf
|
cathepsin F |
chr3_+_61685619 | 6.90 |
ENSRNOT00000002140
|
Hoxd1
|
homeo box D1 |
chr2_-_187160215 | 6.88 |
ENSRNOT00000092780
|
Ntrk1
|
neurotrophic receptor tyrosine kinase 1 |
chr2_-_61414038 | 6.86 |
ENSRNOT00000051910
ENSRNOT00000088202 |
Tars
|
threonyl-tRNA synthetase |
chr3_-_138397508 | 6.84 |
ENSRNOT00000008934
|
Snx5
|
sorting nexin 5 |
chr9_-_88086488 | 6.83 |
ENSRNOT00000019579
|
Irs1
|
insulin receptor substrate 1 |
chr10_+_88764732 | 6.81 |
ENSRNOT00000026662
|
Stat5a
|
signal transducer and activator of transcription 5A |
chr8_+_116826680 | 6.80 |
ENSRNOT00000026854
|
Gmppb
|
GDP-mannose pyrophosphorylase B |
chr4_+_7257752 | 6.75 |
ENSRNOT00000088357
|
Tmub1
|
transmembrane and ubiquitin-like domain containing 1 |
chr3_+_161433410 | 6.75 |
ENSRNOT00000024657
|
Slc12a5
|
solute carrier family 12 member 5 |
chr1_-_198382614 | 6.58 |
ENSRNOT00000055016
|
Asphd1
|
aspartate beta-hydroxylase domain containing 1 |
chr15_-_52443055 | 6.56 |
ENSRNOT00000087450
|
Xpo7
|
exportin 7 |
chr3_+_121490812 | 6.54 |
ENSRNOT00000023913
|
AABR07053707.1
|
|
chr15_+_34234755 | 6.51 |
ENSRNOT00000059987
|
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr2_+_252018597 | 6.48 |
ENSRNOT00000020452
|
Mcoln2
|
mucolipin 2 |
chr7_-_18634079 | 6.47 |
ENSRNOT00000010031
|
Angptl4
|
angiopoietin-like 4 |
chr2_+_209097927 | 6.42 |
ENSRNOT00000023807
|
Dennd2d
|
DENN domain containing 2D |
chr5_-_58124681 | 6.41 |
ENSRNOT00000019795
|
Sigmar1
|
sigma non-opioid intracellular receptor 1 |
chr10_-_85574889 | 6.35 |
ENSRNOT00000072274
|
LOC691153
|
hypothetical protein LOC691153 |
chr19_+_37226186 | 6.35 |
ENSRNOT00000075933
ENSRNOT00000065013 |
Hsf4
|
heat shock transcription factor 4 |
chr2_-_264765085 | 6.31 |
ENSRNOT00000089714
|
LOC103691744
|
cystathionine gamma-lyase |
chr5_-_160352927 | 6.30 |
ENSRNOT00000017247
|
Dnajc16
|
DnaJ heat shock protein family (Hsp40) member C16 |
chr10_+_103396155 | 6.29 |
ENSRNOT00000086924
|
Gprc5c
|
G protein-coupled receptor, class C, group 5, member C |
chr20_-_45053640 | 6.25 |
ENSRNOT00000072256
|
RGD1561777
|
similar to Na+ dependent glucose transporter 1 |
chr7_-_83701447 | 6.22 |
ENSRNOT00000088893
|
AABR07057675.1
|
|
chr6_+_99282850 | 6.21 |
ENSRNOT00000008374
|
Mthfd1
|
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 |
chrX_+_62363953 | 6.17 |
ENSRNOT00000083362
|
Arx
|
aristaless related homeobox |
chr10_+_16970626 | 6.16 |
ENSRNOT00000005383
|
Dusp1
|
dual specificity phosphatase 1 |
chr1_-_256813711 | 6.13 |
ENSRNOT00000021055
|
Rbp4
|
retinol binding protein 4 |
chr7_+_72772440 | 6.11 |
ENSRNOT00000009989
|
Mtdh
|
metadherin |
chr3_+_138398011 | 6.10 |
ENSRNOT00000038865
|
Mgme1
|
mitochondrial genome maintenance exonuclease 1 |
chr4_-_118198029 | 5.97 |
ENSRNOT00000022532
|
Pcyox1
|
prenylcysteine oxidase 1 |
chr20_+_46250363 | 5.94 |
ENSRNOT00000076522
ENSRNOT00000000334 |
Cd164
|
CD164 molecule |
chr16_-_7103604 | 5.94 |
ENSRNOT00000033677
|
Gnl3
|
G protein nucleolar 3 |
chr12_-_9501213 | 5.91 |
ENSRNOT00000071942
|
Pdx1
|
pancreatic and duodenal homeobox 1 |
chr11_-_70499200 | 5.91 |
ENSRNOT00000002439
|
Slc12a8
|
solute carrier family 12, member 8 |
chr3_+_11424099 | 5.88 |
ENSRNOT00000019184
|
Ptges2
|
prostaglandin E synthase 2 |
chr10_+_83476107 | 5.87 |
ENSRNOT00000075733
|
Phb
|
prohibitin |
chr8_+_22050222 | 5.84 |
ENSRNOT00000028096
|
Icam5
|
intercellular adhesion molecule 5 |
chr3_-_5976244 | 5.83 |
ENSRNOT00000009893
|
Vav2
|
vav guanine nucleotide exchange factor 2 |
chr5_-_160282810 | 5.83 |
ENSRNOT00000076160
ENSRNOT00000016352 |
Ddi2
|
DNA-damage inducible protein 2 |
chr7_+_65616177 | 5.81 |
ENSRNOT00000006566
|
Gns
|
glucosamine (N-acetyl)-6-sulfatase |
chr20_+_40778927 | 5.78 |
ENSRNOT00000001081
|
Smpdl3a
|
sphingomyelin phosphodiesterase, acid-like 3A |
chr16_-_81706664 | 5.77 |
ENSRNOT00000026580
|
Lamp1
|
lysosomal-associated membrane protein 1 |
chr1_+_72956026 | 5.77 |
ENSRNOT00000031462
|
Rdh13
|
retinol dehydrogenase 13 |
chr3_+_122803772 | 5.77 |
ENSRNOT00000009564
|
Nop56
|
NOP56 ribonucleoprotein |
chr14_+_4362717 | 5.74 |
ENSRNOT00000002887
|
Barhl2
|
BarH-like homeobox 2 |
chr1_-_164143818 | 5.73 |
ENSRNOT00000022557
|
Dgat2
|
diacylglycerol O-acyltransferase 2 |
chr1_+_203971152 | 5.73 |
ENSRNOT00000075540
|
Gpr26
|
G protein-coupled receptor 26 |
chr3_-_141411170 | 5.71 |
ENSRNOT00000017364
|
Nkx2-2
|
NK2 homeobox 2 |
chr1_+_101687855 | 5.71 |
ENSRNOT00000028546
ENSRNOT00000091597 |
Dbp
|
D-box binding PAR bZIP transcription factor |
chrX_+_62363757 | 5.71 |
ENSRNOT00000091240
|
Arx
|
aristaless related homeobox |
chr4_+_140703619 | 5.69 |
ENSRNOT00000009563
|
Bhlhe40
|
basic helix-loop-helix family, member e40 |
chr9_+_10428853 | 5.68 |
ENSRNOT00000074253
|
Lonp1
|
lon peptidase 1, mitochondrial |
chr2_-_34185682 | 5.67 |
ENSRNOT00000066925
ENSRNOT00000082755 |
Nln
|
neurolysin |
chr12_+_16340922 | 5.65 |
ENSRNOT00000001696
|
Snx8
|
sorting nexin 8 |
chr3_+_58632476 | 5.64 |
ENSRNOT00000010630
|
Rapgef4
|
Rap guanine nucleotide exchange factor 4 |
chr1_+_140584380 | 5.63 |
ENSRNOT00000064438
|
Aen
|
apoptosis enhancing nuclease |
chr16_+_74531564 | 5.63 |
ENSRNOT00000078971
|
Slc25a15
|
solute carrier family 25 member 15 |
chr8_-_111850075 | 5.60 |
ENSRNOT00000082097
|
Cdv3
|
CDV3 homolog |
chr12_+_24473981 | 5.58 |
ENSRNOT00000001973
|
Fzd9
|
frizzled class receptor 9 |
chr8_+_44990014 | 5.57 |
ENSRNOT00000044608
|
Hspa8
|
heat shock protein family A (Hsp70) member 8 |
chr9_+_16543688 | 5.53 |
ENSRNOT00000021868
|
Cnpy3
|
canopy FGF signaling regulator 3 |
chr4_-_82271893 | 5.46 |
ENSRNOT00000075005
|
Hoxa7
|
homeobox A7 |
chr1_+_203160323 | 5.39 |
ENSRNOT00000027919
|
AABR07005844.1
|
|
chr8_+_81863619 | 5.38 |
ENSRNOT00000080608
|
Fam214a
|
family with sequence similarity 214, member A |
chr10_-_63499390 | 5.38 |
ENSRNOT00000032934
|
Bhlha9
|
basic helix-loop-helix family, member a9 |
chr20_-_20713128 | 5.38 |
ENSRNOT00000000784
|
Rhobtb1
|
Rho-related BTB domain containing 1 |
chr1_+_91363492 | 5.36 |
ENSRNOT00000014517
|
Cebpa
|
CCAAT/enhancer binding protein alpha |
chr1_-_222178725 | 5.36 |
ENSRNOT00000028697
|
Esrra
|
estrogen related receptor, alpha |
chr17_-_9837293 | 5.34 |
ENSRNOT00000091320
ENSRNOT00000022134 |
Prelid1
|
PRELI domain containing 1 |
chr1_+_102396538 | 5.34 |
ENSRNOT00000015109
|
Myod1
|
myogenic differentiation 1 |
chr20_-_11737050 | 5.30 |
ENSRNOT00000001637
|
Sumo3
|
small ubiquitin-like modifier 3 |
chr13_+_49074644 | 5.28 |
ENSRNOT00000000041
|
Klhdc8a
|
kelch domain containing 8A |
chr4_+_120671489 | 5.27 |
ENSRNOT00000029125
|
Mgll
|
monoglyceride lipase |
chr1_+_174655939 | 5.26 |
ENSRNOT00000014002
|
Ipo7
|
importin 7 |
chr15_-_3435888 | 5.26 |
ENSRNOT00000016709
|
Adk
|
adenosine kinase |
chr13_-_97838228 | 5.22 |
ENSRNOT00000003618
|
Tfb2m
|
transcription factor B2, mitochondrial |
chrX_-_105355716 | 5.21 |
ENSRNOT00000015043
|
Timm8a1
|
translocase of inner mitochondrial membrane 8 homolog A1 (yeast) |
chr1_-_282170017 | 5.21 |
ENSRNOT00000066947
|
Eif3a
|
eukaryotic translation initiation factor 3, subunit A |
chr3_-_8852192 | 5.15 |
ENSRNOT00000022786
|
Dolk
|
dolichol kinase |
chr7_+_141370491 | 5.14 |
ENSRNOT00000087662
|
Gpd1
|
glycerol-3-phosphate dehydrogenase 1 |
chr16_+_49185560 | 5.13 |
ENSRNOT00000014360
|
Helt
|
helt bHLH transcription factor |
chr7_-_140483693 | 5.13 |
ENSRNOT00000089060
|
Ddn
|
dendrin |
chr20_-_10912769 | 5.12 |
ENSRNOT00000051678
|
RGD1566085
|
similar to pyridoxal (pyridoxine, vitamin B6) kinase |
chr3_-_5975734 | 5.10 |
ENSRNOT00000081376
|
Vav2
|
vav guanine nucleotide exchange factor 2 |
chr2_+_164747677 | 5.07 |
ENSRNOT00000018489
|
Mfsd1
|
major facilitator superfamily domain containing 1 |
chr10_-_88442796 | 5.07 |
ENSRNOT00000077579
ENSRNOT00000023447 ENSRNOT00000043172 |
Acly
|
ATP citrate lyase |
chr2_-_208420163 | 5.06 |
ENSRNOT00000021920
|
LOC100911417
|
ATP synthase subunit b, mitochondrial-like |
chr7_+_144531814 | 5.05 |
ENSRNOT00000033300
|
Hoxc13
|
homeobox C13 |
chr1_-_211265161 | 5.04 |
ENSRNOT00000080041
ENSRNOT00000023477 |
Bnip3
|
BCL2 interacting protein 3 |
chr1_+_263554453 | 5.02 |
ENSRNOT00000070861
|
Abcc2
|
ATP binding cassette subfamily C member 2 |
chr6_-_46631983 | 5.01 |
ENSRNOT00000045963
|
Sox11
|
SRY box 11 |
chr9_-_113331319 | 4.97 |
ENSRNOT00000020681
|
Vapa
|
VAMP associated protein A |
chr4_-_30276372 | 4.92 |
ENSRNOT00000011823
|
Pon1
|
paraoxonase 1 |
chr9_-_20621051 | 4.90 |
ENSRNOT00000015918
|
Tnfrsf21
|
TNF receptor superfamily member 21 |
chr1_-_213981317 | 4.88 |
ENSRNOT00000086238
ENSRNOT00000054869 |
Slc25a22
|
solute carrier family 25 member 22 |
chr4_+_78981987 | 4.85 |
ENSRNOT00000012490
|
Ccdc126
|
coiled-coil domain containing 126 |
chr11_-_61530830 | 4.84 |
ENSRNOT00000059666
ENSRNOT00000068345 |
Naa50
|
N(alpha)-acetyltransferase 50, NatE catalytic subunit |
chr11_-_83985385 | 4.83 |
ENSRNOT00000002334
|
LOC102551435
|
endothelin-converting enzyme 2-like |
chr10_-_56531483 | 4.81 |
ENSRNOT00000022343
|
Eif5a
|
eukaryotic translation initiation factor 5A |
chr10_+_109665682 | 4.78 |
ENSRNOT00000054963
|
Slc25a10
|
solute carrier family 25 member 10 |
chr9_-_93377643 | 4.74 |
ENSRNOT00000024712
|
Ncl
|
nucleolin |
chr13_+_71179910 | 4.73 |
ENSRNOT00000032236
|
Rgs16
|
regulator of G-protein signaling 16 |
chr4_+_95498003 | 4.72 |
ENSRNOT00000008358
|
Atoh1
|
atonal bHLH transcription factor 1 |
chr3_+_114176309 | 4.71 |
ENSRNOT00000023350
|
Sord
|
sorbitol dehydrogenase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.8 | 38.4 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
8.3 | 33.4 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
7.3 | 21.8 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
7.0 | 21.1 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
6.7 | 33.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
4.4 | 8.8 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
4.3 | 25.8 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
4.2 | 12.6 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
4.2 | 12.5 | GO:0089718 | amino acid import across plasma membrane(GO:0089718) |
4.2 | 12.5 | GO:1990792 | response to glial cell derived neurotrophic factor(GO:1990790) cellular response to glial cell derived neurotrophic factor(GO:1990792) |
4.2 | 12.5 | GO:0009609 | response to symbiotic bacterium(GO:0009609) |
4.1 | 16.5 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) |
3.9 | 11.6 | GO:0000053 | argininosuccinate metabolic process(GO:0000053) |
3.6 | 14.5 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
3.3 | 9.9 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
3.2 | 9.7 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
3.1 | 12.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
3.1 | 9.3 | GO:0006552 | leucine catabolic process(GO:0006552) |
3.1 | 9.2 | GO:0009758 | carbohydrate utilization(GO:0009758) |
2.9 | 8.6 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
2.8 | 17.0 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
2.8 | 14.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
2.8 | 11.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
2.7 | 8.2 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
2.7 | 13.3 | GO:0015755 | fructose transport(GO:0015755) |
2.7 | 8.0 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.6 | 18.0 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.6 | 7.7 | GO:0009216 | purine deoxyribonucleotide biosynthetic process(GO:0009153) purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) AMP salvage(GO:0044209) adenosine biosynthetic process(GO:0046086) |
2.5 | 7.5 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
2.4 | 21.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
2.3 | 6.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
2.3 | 4.5 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
2.3 | 13.6 | GO:0019405 | alditol catabolic process(GO:0019405) |
2.2 | 10.8 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
2.2 | 8.6 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
2.1 | 6.4 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
2.1 | 6.3 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
2.0 | 6.1 | GO:0046864 | isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
2.0 | 6.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
2.0 | 11.9 | GO:0021759 | globus pallidus development(GO:0021759) |
2.0 | 3.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.9 | 9.7 | GO:0001582 | detection of chemical stimulus involved in sensory perception of sweet taste(GO:0001582) |
1.9 | 5.8 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
1.9 | 5.8 | GO:0009644 | response to high light intensity(GO:0009644) |
1.9 | 5.7 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
1.9 | 13.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
1.9 | 11.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
1.9 | 5.7 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.8 | 3.7 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
1.7 | 10.5 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
1.7 | 7.0 | GO:0050787 | detoxification of mercury ion(GO:0050787) |
1.7 | 5.1 | GO:0006116 | NADH oxidation(GO:0006116) |
1.7 | 6.8 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
1.7 | 5.0 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.6 | 4.9 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
1.6 | 6.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.6 | 6.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.6 | 6.5 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.6 | 6.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
1.6 | 8.0 | GO:0000050 | urea cycle(GO:0000050) |
1.6 | 4.8 | GO:0071422 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
1.6 | 4.7 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
1.5 | 6.2 | GO:0010999 | regulation of eIF2 alpha phosphorylation by heme(GO:0010999) |
1.5 | 7.7 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
1.5 | 7.5 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.5 | 7.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.5 | 5.9 | GO:0010157 | response to chlorate(GO:0010157) |
1.5 | 5.9 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.5 | 5.8 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
1.4 | 8.6 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
1.4 | 5.7 | GO:0034125 | negative regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034125) |
1.4 | 2.8 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
1.4 | 4.2 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
1.4 | 5.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
1.4 | 4.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
1.4 | 6.8 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.4 | 4.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.3 | 4.0 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
1.3 | 5.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.3 | 15.8 | GO:0046033 | AMP metabolic process(GO:0046033) |
1.3 | 5.2 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
1.3 | 5.2 | GO:0002188 | translation reinitiation(GO:0002188) |
1.3 | 6.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.3 | 5.2 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
1.3 | 6.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
1.3 | 3.8 | GO:1902962 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
1.3 | 6.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
1.3 | 3.8 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.3 | 5.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
1.2 | 2.5 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.2 | 4.9 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.2 | 3.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.2 | 3.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.2 | 7.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.2 | 2.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.2 | 3.6 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
1.2 | 10.5 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
1.2 | 10.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.2 | 3.5 | GO:1903937 | neurofilament bundle assembly(GO:0033693) response to acrylamide(GO:1903937) |
1.1 | 4.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.1 | 3.4 | GO:0032916 | regulation of lung blood pressure(GO:0014916) positive regulation of transforming growth factor beta3 production(GO:0032916) |
1.1 | 3.4 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
1.1 | 4.5 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
1.1 | 3.3 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
1.1 | 3.3 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
1.1 | 5.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.1 | 4.4 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
1.1 | 3.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.1 | 5.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
1.0 | 3.1 | GO:0046416 | aspartate catabolic process(GO:0006533) D-amino acid metabolic process(GO:0046416) |
1.0 | 3.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
1.0 | 1.0 | GO:0046671 | negative regulation of retinal cell programmed cell death(GO:0046671) |
1.0 | 5.1 | GO:1903352 | L-ornithine transmembrane transport(GO:1903352) |
1.0 | 4.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
1.0 | 4.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.0 | 4.0 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
1.0 | 22.7 | GO:0045475 | locomotor rhythm(GO:0045475) |
1.0 | 2.9 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
1.0 | 2.0 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
1.0 | 2.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.0 | 10.6 | GO:1903874 | ferrous iron transport(GO:0015684) zinc II ion transmembrane import(GO:0071578) ferrous iron transmembrane transport(GO:1903874) |
1.0 | 3.8 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
1.0 | 7.6 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.9 | 15.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.9 | 3.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.9 | 5.3 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.9 | 7.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.9 | 4.4 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.9 | 2.6 | GO:0071288 | cellular response to water deprivation(GO:0042631) cellular response to mercury ion(GO:0071288) |
0.9 | 2.6 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.9 | 2.6 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.9 | 3.4 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.9 | 1.7 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.9 | 3.4 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.9 | 2.6 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.8 | 3.4 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.8 | 6.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.8 | 5.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.8 | 1.7 | GO:1904373 | response to kainic acid(GO:1904373) |
0.8 | 3.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.8 | 3.3 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.8 | 4.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.8 | 5.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.8 | 8.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.8 | 4.7 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.8 | 3.1 | GO:1904640 | response to methionine(GO:1904640) |
0.8 | 2.3 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.8 | 5.5 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.8 | 12.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.8 | 4.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.8 | 6.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.7 | 7.4 | GO:0015886 | heme transport(GO:0015886) |
0.7 | 15.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.7 | 4.3 | GO:0045006 | DNA deamination(GO:0045006) |
0.7 | 6.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.7 | 2.1 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.7 | 2.8 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.7 | 3.4 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.7 | 2.0 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.7 | 6.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.7 | 2.0 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.7 | 2.0 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.7 | 2.6 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.7 | 2.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.6 | 2.6 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.6 | 1.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.6 | 2.5 | GO:0035470 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) positive regulation of vascular wound healing(GO:0035470) glomerular endothelium development(GO:0072011) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
0.6 | 8.7 | GO:0031167 | rRNA methylation(GO:0031167) |
0.6 | 2.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.6 | 2.5 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
0.6 | 6.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.6 | 2.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.6 | 3.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.6 | 5.3 | GO:0035878 | nail development(GO:0035878) |
0.6 | 1.7 | GO:0034696 | response to prostaglandin F(GO:0034696) |
0.6 | 8.0 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.6 | 1.7 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
0.6 | 7.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.6 | 3.9 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.6 | 2.2 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.5 | 9.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.5 | 1.1 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.5 | 8.7 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.5 | 1.6 | GO:1903165 | response to polycyclic arene(GO:1903165) |
0.5 | 3.2 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.5 | 3.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.5 | 15.6 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.5 | 1.6 | GO:0045578 | pro-T cell differentiation(GO:0002572) negative regulation of B cell differentiation(GO:0045578) |
0.5 | 2.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.5 | 2.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.5 | 1.5 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.5 | 2.1 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.5 | 2.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.5 | 3.0 | GO:0097068 | response to thyroxine(GO:0097068) |
0.5 | 3.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.5 | 22.7 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.5 | 2.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.5 | 15.4 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.5 | 6.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 1.5 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.5 | 1.4 | GO:0070084 | protein initiator methionine removal(GO:0070084) |
0.5 | 5.7 | GO:0010044 | response to aluminum ion(GO:0010044) |
0.5 | 1.4 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.5 | 4.2 | GO:0046051 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.5 | 2.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 5.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.5 | 1.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.5 | 2.7 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.5 | 1.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.5 | 4.5 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.4 | 1.3 | GO:0071387 | cellular response to cortisol stimulus(GO:0071387) |
0.4 | 2.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.4 | 3.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 3.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 1.7 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.4 | 2.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.4 | 5.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 6.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.4 | 1.3 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
0.4 | 1.3 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.4 | 2.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.4 | 3.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 1.2 | GO:0070946 | neutrophil mediated killing of gram-positive bacterium(GO:0070946) |
0.4 | 2.8 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 4.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.4 | 1.6 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.4 | 0.8 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.4 | 3.0 | GO:0097459 | iron ion import into cell(GO:0097459) iron ion import across plasma membrane(GO:0098711) |
0.4 | 1.5 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.4 | 1.5 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.4 | 3.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.4 | 2.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.4 | 1.5 | GO:0070370 | cellular heat acclimation(GO:0070370) |
0.4 | 1.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.4 | 2.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 1.1 | GO:0021570 | rhombomere 3 development(GO:0021569) rhombomere 4 development(GO:0021570) |
0.4 | 2.9 | GO:0035646 | endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.4 | 4.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.4 | 2.2 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.4 | 0.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.4 | 7.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.3 | 11.4 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.3 | 4.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 1.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.3 | 1.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 0.7 | GO:0015746 | citrate transport(GO:0015746) |
0.3 | 5.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 1.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.3 | 3.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.3 | 1.3 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
0.3 | 1.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 1.6 | GO:1904400 | response to Thyroid stimulating hormone(GO:1904400) cellular response to Thyroid stimulating hormone(GO:1904401) |
0.3 | 2.6 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.3 | 1.9 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.3 | 2.5 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.3 | 1.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 12.5 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.3 | 1.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.3 | 0.9 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.3 | 0.9 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.3 | 1.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 2.4 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 3.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.3 | 2.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.3 | 6.5 | GO:0001502 | cartilage condensation(GO:0001502) |
0.3 | 0.9 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.3 | 4.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 8.1 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.3 | 4.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 2.3 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.3 | 10.9 | GO:0021762 | substantia nigra development(GO:0021762) |
0.3 | 5.5 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 1.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 5.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 0.5 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.3 | 1.6 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 2.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 2.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.8 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.3 | 3.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.3 | 1.0 | GO:0034059 | response to anoxia(GO:0034059) |
0.3 | 0.5 | GO:0046075 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) dTTP metabolic process(GO:0046075) |
0.3 | 1.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 1.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 3.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.3 | 3.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 3.2 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.2 | 1.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 2.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 5.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 4.6 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 0.5 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
0.2 | 12.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 1.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 4.6 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.2 | 0.9 | GO:0060702 | regulation of endoribonuclease activity(GO:0060699) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.2 | 6.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 2.3 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 6.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 1.1 | GO:1905216 | positive regulation of RNA binding(GO:1905216) |
0.2 | 2.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 3.8 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.2 | 10.0 | GO:0061515 | myeloid cell development(GO:0061515) |
0.2 | 2.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 3.9 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 1.4 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.2 | 1.4 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.2 | 1.2 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.2 | 2.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 0.8 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.2 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 2.9 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 4.0 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 1.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 1.3 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.2 | 0.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.4 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 4.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 1.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 6.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 1.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 2.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.2 | 0.9 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 2.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 3.5 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 1.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 1.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.2 | 0.4 | GO:0032258 | CVT pathway(GO:0032258) |
0.2 | 2.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 1.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 3.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 4.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 1.5 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 1.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 1.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 2.0 | GO:0032369 | negative regulation of lipid transport(GO:0032369) |
0.2 | 1.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 0.8 | GO:0018963 | phthalate metabolic process(GO:0018963) granulosa cell differentiation(GO:0060014) |
0.2 | 0.8 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.2 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 1.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.2 | 0.9 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 1.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 1.3 | GO:0046479 | ganglioside catabolic process(GO:0006689) glycosphingolipid catabolic process(GO:0046479) |
0.1 | 1.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 1.5 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 3.8 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 1.0 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 1.3 | GO:0072506 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.1 | 0.4 | GO:0021508 | floor plate formation(GO:0021508) |
0.1 | 0.4 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.1 | 1.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 0.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 2.6 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 1.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 1.2 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.1 | 1.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 3.0 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 2.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.1 | 0.4 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.1 | 1.8 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 4.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 2.7 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 1.4 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 2.6 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 4.2 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 1.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.6 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 5.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 1.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 0.2 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.1 | 2.6 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 1.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 2.9 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 1.7 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.3 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.1 | 1.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 6.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.7 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 1.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
0.1 | 2.1 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.1 | 3.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 2.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 1.7 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 5.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 1.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.7 | GO:0010668 | ectodermal cell differentiation(GO:0010668) chorio-allantoic fusion(GO:0060710) |
0.1 | 1.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.5 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 1.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 1.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.1 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
0.1 | 2.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.8 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 2.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 2.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 1.7 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.4 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.6 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 0.7 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 4.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 1.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 4.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 2.9 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
0.1 | 0.3 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.7 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 2.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 0.7 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 2.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 2.4 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.1 | 0.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.6 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.2 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 1.6 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 2.0 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 1.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 1.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 4.7 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.1 | 0.2 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 2.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.4 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.6 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.6 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.1 | 1.9 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.1 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.1 | 0.5 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 1.3 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 0.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 1.1 | GO:0060384 | innervation(GO:0060384) |
0.0 | 0.6 | GO:0006639 | acylglycerol metabolic process(GO:0006639) |
0.0 | 1.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 1.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 2.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 1.7 | GO:0007595 | lactation(GO:0007595) |
0.0 | 0.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 1.2 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 2.9 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 3.0 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 1.5 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.6 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.1 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling(GO:0060683) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) embryonic lung development(GO:1990401) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.0 | 1.3 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 0.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 4.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 1.7 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.7 | GO:0097502 | mannosylation(GO:0097502) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.4 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.0 | 0.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.2 | GO:0060433 | bronchus development(GO:0060433) |
0.0 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.1 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.0 | 1.5 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.2 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.3 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 1.2 | GO:2000648 | positive regulation of stem cell proliferation(GO:2000648) |
0.0 | 0.9 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.0 | 1.1 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 1.4 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 0.5 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.5 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.0 | 0.1 | GO:0006272 | leading strand elongation(GO:0006272) |
0.0 | 0.5 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.4 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.0 | 1.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:2001171 | regulation of ATP biosynthetic process(GO:2001169) positive regulation of ATP biosynthetic process(GO:2001171) |
0.0 | 1.4 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.8 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 3.0 | GO:0048511 | rhythmic process(GO:0048511) |
0.0 | 0.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.4 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 1.7 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.0 | 0.4 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.5 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
0.0 | 1.6 | GO:0016042 | lipid catabolic process(GO:0016042) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.6 | GO:0005960 | glycine cleavage complex(GO:0005960) |
3.8 | 19.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
3.8 | 11.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
3.0 | 15.1 | GO:0097413 | Lewy body(GO:0097413) |
2.9 | 23.0 | GO:0097452 | GAIT complex(GO:0097452) |
2.8 | 14.1 | GO:0070552 | BRISC complex(GO:0070552) |
2.5 | 15.2 | GO:0097422 | tubular endosome(GO:0097422) |
2.3 | 11.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
2.3 | 6.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.1 | 14.4 | GO:0031415 | NatA complex(GO:0031415) |
1.9 | 9.7 | GO:1903767 | sweet taste receptor complex(GO:1903767) taste receptor complex(GO:1903768) |
1.9 | 7.5 | GO:0070876 | SOSS complex(GO:0070876) |
1.9 | 5.6 | GO:1990836 | lysosomal matrix(GO:1990836) |
1.8 | 5.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.4 | 5.8 | GO:0061474 | phagolysosome membrane(GO:0061474) |
1.4 | 9.8 | GO:0001674 | female germ cell nucleus(GO:0001674) |
1.4 | 6.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
1.3 | 6.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.3 | 3.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.3 | 5.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.2 | 4.9 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.2 | 14.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
1.2 | 5.9 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.1 | 5.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.1 | 13.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.0 | 5.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.0 | 4.0 | GO:0018444 | translation release factor complex(GO:0018444) |
1.0 | 6.8 | GO:0005827 | polar microtubule(GO:0005827) |
0.9 | 3.7 | GO:0072487 | MSL complex(GO:0072487) |
0.9 | 4.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.9 | 2.6 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.9 | 6.0 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.8 | 6.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.8 | 2.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.8 | 2.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.8 | 10.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.8 | 4.8 | GO:0005642 | annulate lamellae(GO:0005642) |
0.8 | 15.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.7 | 11.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.7 | 5.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.7 | 6.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.7 | 6.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.7 | 2.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.7 | 2.0 | GO:0032398 | MHC class Ib protein complex(GO:0032398) |
0.6 | 18.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.6 | 32.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.6 | 4.4 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 3.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.6 | 7.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.6 | 2.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.6 | 3.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.6 | 4.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.6 | 2.3 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.6 | 3.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.6 | 5.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.6 | 3.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.5 | 14.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.5 | 2.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.5 | 2.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.5 | 2.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.5 | 1.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.5 | 4.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 2.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.5 | 3.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.5 | 2.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.5 | 34.7 | GO:0031901 | early endosome membrane(GO:0031901) |
0.5 | 1.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 9.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.4 | 4.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.4 | 5.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.4 | 110.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.4 | 3.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.4 | 1.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 1.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 4.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 10.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.4 | 4.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 1.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.4 | 4.0 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.4 | 5.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.4 | 5.3 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 13.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 0.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.3 | 3.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 19.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 2.7 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 3.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.3 | 10.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 3.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 2.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.3 | 0.3 | GO:0070069 | cytochrome complex(GO:0070069) |
0.3 | 5.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 0.3 | GO:0098830 | presynaptic endosome(GO:0098830) |
0.3 | 1.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.3 | 2.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 3.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.3 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 5.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 4.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 0.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 3.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 5.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 1.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 4.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 3.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 72.1 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 1.1 | GO:0034455 | t-UTP complex(GO:0034455) |
0.2 | 2.0 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.2 | 34.9 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.2 | 4.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 1.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 1.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.8 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 13.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 1.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 2.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 3.5 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 0.7 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 9.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 1.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 1.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 8.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 2.7 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.2 | 10.0 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.5 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 0.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 2.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 4.4 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 142.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 2.0 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.1 | 13.6 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 2.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 2.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 7.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 6.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.2 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
0.1 | 0.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 2.6 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 2.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 6.8 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 1.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.4 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 3.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 4.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 2.2 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.1 | 0.7 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 1.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.9 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 8.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 6.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.3 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.0 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 2.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 7.1 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.0 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 2.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 7.4 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 2.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 2.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 4.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 3.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 1.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 1.5 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 2.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 2.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 1.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 1.7 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 6.5 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.4 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.0 | 5.6 | GO:0030424 | axon(GO:0030424) |
0.0 | 13.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 2.9 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 1.6 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.0 | 1.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 10.3 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 3.7 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 3.8 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 1.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 1.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 4.0 | GO:0005768 | endosome(GO:0005768) |
0.0 | 1.4 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 1.5 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.0 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 1.5 | GO:0031253 | cell projection membrane(GO:0031253) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 1.0 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0001940 | female pronucleus(GO:0001939) male pronucleus(GO:0001940) |
0.0 | 1.3 | GO:0005840 | ribosome(GO:0005840) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.1 | 33.4 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
7.1 | 21.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
5.3 | 21.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
4.8 | 14.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
4.7 | 14.1 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
4.1 | 16.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
4.1 | 20.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
3.6 | 14.5 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
3.2 | 22.4 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
3.0 | 9.0 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
2.9 | 8.6 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
2.8 | 11.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.7 | 8.0 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
2.5 | 20.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.5 | 15.1 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
2.5 | 9.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
2.4 | 7.3 | GO:0016822 | oxaloacetate decarboxylase activity(GO:0008948) hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
2.4 | 9.7 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
2.3 | 6.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
2.2 | 22.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
2.1 | 6.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
2.0 | 5.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
2.0 | 5.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.9 | 11.4 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
1.9 | 5.7 | GO:0070012 | oligopeptidase activity(GO:0070012) |
1.9 | 5.6 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
1.8 | 7.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
1.8 | 37.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
1.8 | 5.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.8 | 10.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.7 | 5.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
1.7 | 8.6 | GO:0004586 | ornithine decarboxylase activity(GO:0004586) |
1.7 | 11.9 | GO:0034452 | dynactin binding(GO:0034452) |
1.6 | 4.9 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.6 | 4.8 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
1.6 | 7.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.6 | 6.2 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.5 | 7.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.5 | 4.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.5 | 5.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.4 | 5.7 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.4 | 10.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.4 | 12.9 | GO:0070061 | fructose binding(GO:0070061) |
1.4 | 28.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
1.4 | 5.6 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.4 | 4.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.3 | 16.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.3 | 12.0 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
1.3 | 5.1 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) |
1.3 | 3.8 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
1.3 | 3.8 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.2 | 4.9 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.2 | 4.7 | GO:0033149 | FFAT motif binding(GO:0033149) |
1.2 | 4.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.2 | 10.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
1.2 | 4.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.2 | 9.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
1.1 | 21.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.1 | 4.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.1 | 3.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.1 | 3.3 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
1.1 | 10.8 | GO:0050693 | LBD domain binding(GO:0050693) |
1.1 | 4.2 | GO:0030984 | kininogen binding(GO:0030984) |
1.0 | 8.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.0 | 4.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.0 | 5.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.0 | 4.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.0 | 4.0 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
1.0 | 3.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.0 | 2.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.0 | 4.9 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
1.0 | 6.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.9 | 2.7 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.9 | 8.5 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.9 | 6.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.8 | 2.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.8 | 11.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.8 | 8.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.8 | 3.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.8 | 5.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.8 | 2.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.8 | 6.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.8 | 2.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.8 | 15.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.8 | 7.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.8 | 9.7 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.8 | 4.9 | GO:0031386 | protein tag(GO:0031386) |
0.8 | 5.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.8 | 3.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.8 | 10.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.8 | 6.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.8 | 3.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.8 | 5.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.7 | 2.1 | GO:0031721 | haptoglobin binding(GO:0031720) hemoglobin alpha binding(GO:0031721) |
0.7 | 7.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.7 | 2.1 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
0.7 | 3.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.7 | 2.8 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.7 | 32.4 | GO:0070888 | E-box binding(GO:0070888) |
0.7 | 10.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.7 | 3.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 3.3 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.7 | 3.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.7 | 7.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.6 | 3.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.6 | 1.9 | GO:0036470 | tyrosine 3-monooxygenase activator activity(GO:0036470) L-dopa decarboxylase activator activity(GO:0036478) |
0.6 | 1.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.6 | 6.4 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.6 | 3.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.6 | 7.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 2.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.6 | 12.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.6 | 6.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 3.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 4.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.6 | 2.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.6 | 2.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.6 | 11.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.6 | 6.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.6 | 2.3 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.6 | 4.5 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.5 | 4.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.5 | 11.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.5 | 3.7 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.5 | 2.1 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.5 | 2.6 | GO:0015168 | polyol transmembrane transporter activity(GO:0015166) glycerol transmembrane transporter activity(GO:0015168) |
0.5 | 2.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.5 | 3.0 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.5 | 8.5 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 3.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.5 | 3.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.5 | 2.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.5 | 11.0 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.5 | 6.1 | GO:0019841 | retinol binding(GO:0019841) |
0.5 | 2.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 2.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.5 | 8.7 | GO:0030955 | potassium ion binding(GO:0030955) |
0.5 | 1.4 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
0.4 | 1.8 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 1.3 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.4 | 2.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 8.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.4 | 1.3 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
0.4 | 1.3 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.4 | 3.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.4 | 3.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.4 | 5.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 2.8 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.4 | 24.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.4 | 3.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 3.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 2.0 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.4 | 2.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.4 | 1.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.4 | 3.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.4 | 2.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 4.0 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.4 | 1.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 3.5 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.3 | 1.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 3.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 0.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) |
0.3 | 1.0 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.3 | 11.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 4.0 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.3 | 7.8 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.3 | 8.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.3 | 1.6 | GO:0004104 | choline kinase activity(GO:0004103) cholinesterase activity(GO:0004104) |
0.3 | 13.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 2.3 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) |
0.3 | 0.9 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
0.3 | 2.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 10.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 4.3 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 3.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 9.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 11.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.3 | 13.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 1.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 2.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 2.9 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.3 | 1.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 1.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 0.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.3 | 2.6 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 3.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 3.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 5.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 2.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 3.8 | GO:0042166 | acetylcholine-gated cation channel activity(GO:0022848) acetylcholine binding(GO:0042166) |
0.2 | 1.2 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 1.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 2.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 1.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 4.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 5.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.9 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.2 | 7.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 5.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.2 | 2.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 1.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 1.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 65.5 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.2 | 2.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 3.1 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.2 | 1.0 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.2 | 1.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 4.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 2.9 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 2.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 1.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 6.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 2.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 5.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.2 | 1.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 2.0 | GO:0015924 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 0.9 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 1.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 1.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 1.7 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.7 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.2 | 8.6 | GO:0051287 | NAD binding(GO:0051287) |
0.2 | 0.8 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 1.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 1.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 2.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 5.7 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 3.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 6.4 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 1.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 2.6 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 1.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 2.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 19.0 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 3.5 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 2.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 9.4 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.1 | 1.0 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 2.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 1.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 1.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 1.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.8 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 1.0 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 2.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 23.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 2.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.7 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 3.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.6 | GO:0015605 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) organophosphate ester transmembrane transporter activity(GO:0015605) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 2.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.5 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 7.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 1.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 1.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 1.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 3.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 5.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 1.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 3.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 1.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 2.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.6 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 2.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 1.4 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.1 | 9.7 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 2.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 1.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.3 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 3.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 4.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 1.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.4 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 0.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 4.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 1.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 1.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.0 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.6 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.0 | 2.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 1.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 3.9 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.0 | 1.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 3.1 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 0.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.0 | 1.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 1.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 2.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 2.9 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 6.2 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 5.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.4 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 3.7 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 1.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 23.4 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 1.8 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 6.8 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 4.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.9 | 21.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.7 | 68.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.7 | 8.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.7 | 7.5 | ST STAT3 PATHWAY | STAT3 Pathway |
0.7 | 14.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.6 | 10.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.6 | 14.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.6 | 34.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 15.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.4 | 6.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 3.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 3.9 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 7.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 10.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 6.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 12.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 1.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 9.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 8.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 2.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 9.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 2.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 2.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 5.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 3.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 3.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 7.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 3.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 5.5 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 3.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 4.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 3.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 2.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 3.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 2.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 3.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 2.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 1.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.6 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 47.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
2.1 | 24.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.9 | 33.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.8 | 27.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.6 | 59.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
1.2 | 12.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.2 | 8.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
1.1 | 14.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.1 | 18.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.0 | 17.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.0 | 44.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.9 | 24.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.9 | 15.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.8 | 7.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.8 | 10.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.8 | 12.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.7 | 13.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.7 | 24.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.6 | 8.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.6 | 9.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.6 | 10.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.6 | 23.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.6 | 11.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.6 | 10.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.6 | 7.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.5 | 13.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.5 | 2.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.5 | 20.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 0.9 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.4 | 9.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 3.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 16.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.4 | 5.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 7.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.4 | 6.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 7.7 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.4 | 5.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 5.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 6.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 4.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 6.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 4.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 6.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.4 | 18.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.4 | 2.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 6.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 16.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 23.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 4.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 16.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 4.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 8.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 2.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 7.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 3.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 1.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 7.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 1.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 3.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 7.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 5.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 1.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 1.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 1.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 15.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 2.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 4.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 0.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 2.7 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 1.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 3.5 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.1 | 6.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 2.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 3.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 4.2 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 3.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.9 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 3.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 2.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 3.1 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 2.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 3.8 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 11.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 3.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 3.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 2.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.6 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 0.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 2.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 9.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 7.0 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.8 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 0.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 1.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 1.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 1.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 1.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.7 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 1.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.3 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 0.3 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.6 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 1.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |